The Effect of Hepatic Impairment on Aprocitentan Pharmacokinetics
Clinical trial NCT04252495 · COMPLETED
Trial details
- NCT number
- NCT04252495
- Sponsor
- Idorsia Pharmaceuticals Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-26
- Primary completion
- 2021-04-05
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.